Innovative diosmin formulation featuring dramatically enhanced absorption and bioavailability.
Benefits
Diosmin, a citrus flavonoid derived from hesperidin, has a long history of use as a vascular protecting compound primarily for the management of chronic venous insufficiency (CVI), hemorrhoids, varicose veins, and lymphedema.
Active: diosmin (NLT 80% by HPLC)
Extract Type: granulated powder
Recommended Dosage: 570 mg from one to three times daily depending on health goals
Applications: powders, tablets, hard shell capsules
USP and features
- Superior alternative to the standard form of diosmin currently sold in the market
- Pre-clinical and clinical bioavailability studies (published)
- Efficacy human clinical trial (published)
- 9x increased bioavailability vs standard micronized diosmin, after oral supplementation
- Great flowability and compressibility
- Residual solvents < 1 ppm
Scientific evidence/Proprietary studies
Pharmacokinetic profile of µsmin® Plus (Microsmin Plus), a new micronized diosmin formulation, after oral administration in rats (Russo et al 2015). Comparative Bioavailability of Two Diosmin Formulations after Oral Administration to Healthy Volunteers (Russo et al 2018). Efficacy of a Low‐Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double‐Blind, Placebo‐Controlled Trial (Serra et al 2021).
